These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12369983)

  • 1. Quantitative structure-activity relationship (QSAR) paradigm--Hansch era to new millennium.
    Debnath AK
    Mini Rev Med Chem; 2001 Jul; 1(2):187-95. PubMed ID: 12369983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-QSAR in drug design--a review.
    Verma J; Khedkar VM; Coutinho EC
    Curr Top Med Chem; 2010; 10(1):95-115. PubMed ID: 19929826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in multidimensional QSAR (4D-6D): a critical review.
    Damale MG; Harke SN; Kalam Khan FA; Shinde DB; Sangshetti JN
    Mini Rev Med Chem; 2014 Jan; 14(1):35-55. PubMed ID: 24195665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state and perspectives of 3D-QSAR.
    Akamatsu M
    Curr Top Med Chem; 2002 Dec; 2(12):1381-94. PubMed ID: 12470286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for applying the quantitative structure-activity relationship paradigm.
    Esposito EX; Hopfinger AJ; Madura JD
    Methods Mol Biol; 2004; 275():131-214. PubMed ID: 15141113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on principles, theory and practices of 2D-QSAR.
    Roy K; Das RN
    Curr Drug Metab; 2014; 15(4):346-79. PubMed ID: 25204823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obituary: Corwin H. Hansch.
    Selassie CR
    J Comput Aided Mol Des; 2011 Jun; 25(6):493-4. PubMed ID: 21691812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design.
    Du QS; Huang RB; Chou KC
    Curr Protein Pept Sci; 2008 Jun; 9(3):248-60. PubMed ID: 18537680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.
    Perkins R; Fang H; Tong W; Welsh WJ
    Environ Toxicol Chem; 2003 Aug; 22(8):1666-79. PubMed ID: 12924569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
    Du QS; Huang RB; Wei YT; Pang ZW; Du LQ; Chou KC
    J Comput Chem; 2009 Jan; 30(2):295-304. PubMed ID: 18613071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor dependent multidimensional QSAR for modeling drug--receptor interactions.
    Polanski J
    Curr Med Chem; 2009; 16(25):3243-57. PubMed ID: 19548875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor-dependent QSAR paradigm: an overview of the current state of the art.
    Santos-Filho OA; Hopfinger AJ; Cherkasov A; de Alencastro RB
    Med Chem; 2009 Jul; 5(4):359-66. PubMed ID: 19689393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparse QSAR modelling methods for therapeutic and regenerative medicine.
    Winkler DA
    J Comput Aided Mol Des; 2018 Apr; 32(4):497-509. PubMed ID: 29445894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
    Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
    Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of quantitative structure-activity relationships and its application in rational drug design.
    Yang GF; Huang X
    Curr Pharm Des; 2006; 12(35):4601-11. PubMed ID: 17168765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In tribute to Corwin Hansch, father of QSAR.
    Martin Y; Stouch T
    J Comput Aided Mol Des; 2011 Jun; 25(6):491. PubMed ID: 21710390
    [No Abstract]   [Full Text] [Related]  

  • 18. Ensemble QSAR: a QSAR method based on conformational ensembles and metric descriptors.
    Pissurlenkar RR; Khedkar VM; Iyer RP; Coutinho EC
    J Comput Chem; 2011 Jul; 32(10):2204-18. PubMed ID: 21509786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions.
    Prasanth Kumar S; Jasrai YT; Pandya HA; Rawal RM
    J Biomol Struct Dyn; 2015; 33(1):56-69. PubMed ID: 24266725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-based design: formalism and application of receptor-dependent RD-4D-QSAR analysis to a set of glucose analogue inhibitors of glycogen phosphorylase.
    Pan D; Tseng Y; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(5):1591-607. PubMed ID: 14502494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.